What is ACET stock price today?

ACET (Adicet Bio Inc) stock is trading at $8.67 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ACET stock going up or down today?

ACET stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACET stock now?

The decision to buy ACET depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACET a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACET based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACET stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACET is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACET's P/E ratio?

P/E ratio data for ACET will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACET's market cap?

ACET (Adicet Bio Inc) has a market capitalization of $0.08 billion, making it a small-cap stock.

What is ACET's price to book ratio?

ACET trades at a price-to-book (P/B) ratio of 0.50, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ACET pay dividends?

ACET does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACET's dividend yield?

ACET does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACET stock a good long-term investment?

ACET's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACET's revenue growth rate?

ACET has shown revenue growth of -1.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for ACET are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACET?

Key risks for ACET include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACET compare to its competitors?

Compare ACET to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACET's performance and positioning.

What is ACET's stock price target for 2026?

Our AI model provides price targets for ACET based on fundamental analysis: Bull case $11.27 (+30%), Base case $9.97 (+15%), Bear case $7.80 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ACET?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACET. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACET's next earnings report?

ACET reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACET - Adicet Bio Inc

NYSE * Health Care * Biotechnology

$8.67

+$0.45 (+5.47%)

About Adicet Bio Inc

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. The company's lead product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR that targets CD20 for the potential treatment of autoimmune diseases. It also develops ADI-212, a gene-edited and armored clinical candidate that targets prostate-specific membrane antigen. The company was founded in 2014 and is based in Boston, Massachusetts.

ACET Key Statistics

Market Cap

$83.23M

P/B Ratio

0.50

EPS

$-16.95

Revenue Growth

-1.0%

Employees

102

How ACET Compares to Peers

ACET is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACET(This stock)	$83.23M	N/A	-1%	0.0%	-
AMGNAmgen Inc	$191.53B	24.9	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.91B	20.9	-0%	0.1%	vs BIIB

Adicet Bio Inc Company Information

Headquarters: Massachusetts; U.S.A
Website: www.adicetbio.com
Sector: Health Care
Industry: Biotechnology

Data Updated: April 21, 2026 at 4:00 PM EDT

Ready to invest in ACET?

Commission-free trading available. Affiliate links.

ACET Lician Score

5% confidence

4.0/10

Neutral

ACET has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ACETacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ACET Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ACET

Dashboard

Enter a ticker to analyze